NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/23/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization742.51 mln
Float18.42 mln
Earnings Date08/20/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
99
/ 100
Top performer
Debt / Equity
-3.17
Negative equity
ROE
-425
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Adlai Nortye Ltd. is a Cayman Islands-based company founded in 2004 that focuses on developing new cancer treatments across the United States and other markets. The company has several drugs in early-stage clinical trials, targeting a range of cancers including pancreatic, lung, colorectal, esophageal, and rectal cancer. Its pipeline includes treatments that work by helping the immune system recognize and attack tumors, as well as drugs that block specific proteins known to drive cancer growth.
